Patent intelligence · Companies
Company patent strength
Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead — toggle to foreign applicants to see who is entering the Indian market.
Free to browse the ranking. Sign into open a filer's full profile — inventors, filing trend and quality index. See how we rank.
Why this page exists — and how to read it
Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.
- Investors
- High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
- Founders & operators
- These are the incumbents and potential acquirers in your space — open a filer to see the walls you'd build against.
- Corporate & R&D
- Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.
💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.
3,207 foreign filers with 5+ patents · page 50
| # | Filer | Patents↓ | Granted↓ | Lapsed↓ | Pending↓ | Active |
|---|---|---|---|---|---|---|
| 2451 | MYCOTECHNOLOGY | 6 | 00% | 0 | 6 | 2023–2025 |
| 2452 | NCR VOYIX | 6 | 233.3% | 0 | 4 | 2021–2025 |
| 2453 | NEC ONCOIMMUNITY AS | 6 | 116.7% | 1 | 4 | 2021–2025 |
| 2454 | NEOPHORE | 6 | 00% | 1 | 5 | 2022–2025 |
| 2455 | NETZSCH FEINMAHLTECHNIK | 6 | 00% | 0 | 6 | 2022–2025 |
| 2456 | NEUROCHASE TECHNOLOGIES | 6 | 00% | 0 | 6 | 2023–2026 |
| 2457 | NEWTECH GROUP | 6 | 00% | 0 | 6 | 2023–2025 |
| 2458 | NGM BIOPHARMACEUTICALS | 6 | 00% | 0 | 6 | 2022–2024 |
| 2459 | NIPPON FIBER | 6 | 00% | 0 | 6 | 2022–2025 |
| 2460 | NIPPON LIGHT METAL | 6 | 233.3% | 0 | 4 | 2022–2025 |
| 2461 | NIPPON PAINT INDUSTRIAL COATINGS | 6 | 00% | 1 | 5 | 2022–2024 |
| 2462 | NISSIN FOODS HOLDINGS | 6 | 00% | 0 | 6 | 2022–2024 |
| 2463 | NKARTA | 6 | 00% | 0 | 6 | 2022–2025 |
| 2464 | NOK | 6 | 233.3% | 0 | 4 | 2022–2026 |
| 2465 | NRG THERAPEUTICS | 6 | 00% | 0 | 6 | 2023–2026 |
| 2466 | NUOVA OMPI S R L UNIPERSONALE | 6 | 00% | 0 | 6 | 2023–2024 |
| 2467 | NUTCRACKER THERAPEUTICS | 6 | 00% | 3 | 3 | 2022–2024 |
| 2468 | NUTRECO IP ASSETS | 6 | 00% | 1 | 5 | 2022–2026 |
| 2469 | NUTS HOLDINGS | 6 | 00% | 0 | 6 | 2022–2026 |
| 2470 | NYKODE THERAPEUTICS ASA | 6 | 00% | 0 | 6 | 2022–2024 |
| 2471 | OBRIST CLOSURES SWITZERLAND | 6 | 00% | 0 | 6 | 2022–2025 |
| 2472 | OERLIKON METCO US | 6 | 116.7% | 0 | 5 | 2022–2025 |
| 2473 | OERLIKON METCO WOHLEN | 6 | 00% | 0 | 6 | 2023–2025 |
| 2474 | OETIKER SCHWEIZ | 6 | 350% | 0 | 3 | 2022–2025 |
| 2475 | OJJO | 6 | 116.7% | 0 | 5 | 2022–2023 |
| 2476 | OLIMENT | 6 | 00% | 0 | 6 | 2024–2026 |
| 2477 | OMRON | 6 | 00% | 0 | 6 | 2025–2026 |
| 2478 | ONCOC4 | 6 | 00% | 0 | 6 | 2023–2026 |
| 2479 | ONCONIC THERAPEUTICS | 6 | 00% | 0 | 6 | 2023–2025 |
| 2480 | ORGANO | 6 | 350% | 0 | 3 | 2022–2026 |
| 2481 | ORIGIN | 6 | 116.7% | 3 | 2 | 2022–2026 |
| 2482 | ORUM THERAPEUTICS | 6 | 00% | 0 | 6 | 2022–2025 |
| 2483 | OSAKA GAS | 6 | 116.7% | 0 | 5 | 2021–2025 |
| 2484 | OTIS ELEVATOR | 6 | 00% | 0 | 6 | 2022–2025 |
| 2485 | OTTA | 6 | 350% | 0 | 3 | 2022–2026 |
| 2486 | P WAVER | 6 | 00% | 3 | 3 | 2023–2023 |
| 2487 | PANASONIC | 6 | 00% | 0 | 6 | 2024–2025 |
| 2488 | PARIKH HOLDINGS | 6 | 00% | 0 | 6 | 2022–2026 |
| 2489 | PATHY MEDICAL | 6 | 00% | 6 | 0 | 2022–2023 |
| 2490 | PFEIFFER VACUUM | 6 | 00% | 0 | 6 | 2025–2026 |
| 2491 | PFETCH | 6 | 00% | 0 | 6 | 2022–2026 |
| 2492 | PHARMA CINQ | 6 | 00% | 0 | 6 | 2023–2025 |
| 2493 | PHARMAZZ | 6 | 116.7% | 0 | 5 | 2023–2025 |
| 2494 | PI CARDIA | 6 | 00% | 0 | 6 | 2023–2026 |
| 2495 | PINOTBIO | 6 | 00% | 0 | 6 | 2022–2025 |
| 2496 | PLATINUM PHARMA SERVICE S R L S | 6 | 00% | 1 | 5 | 2022–2024 |
| 2497 | POLY MED | 6 | 00% | 0 | 6 | 2022–2025 |
| 2498 | POLYN TECHNOLOGY | 6 | 00% | 0 | 6 | 2022–2026 |
| 2499 | PRO MED INSTRUMENTS | 6 | 00% | 0 | 6 | 2022–2025 |
| 2500 | PROGRESS RAIL LOCOMOTIVE | 6 | 00% | 0 | 6 | 2024–2024 |
Educational institutes are excluded — see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →
Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy — directional, not advice; see methodology. Read the ranking methodology →